 LoginSearch the Site |
$TZYM Extends $BMY Pact, Expects Initial Phase 3 Results in Spring 2012
publication date: Jan 20, 2012
If you're not a subscriber why not join today? If you are already a subscriber, please login. To gain access to the members only content click here to subscribe. You will be given immediate access to premium content on the site including: - Detailed Reports on Upcoming FDA / Clinical Trades - Analyst Reports with consistently updated summaries - Run-Up Valuation Studies - Weekly Newsletter - Email / SMS (Text Message) Alerts of critical news - Screenshots of BioRunUp's and Mike Havrilla's Trading Accounts - BioRunUp Forums - A community of informed traders - A More Detailed FDA Calendar - Increased Organization of Tracking Upcoming Catalysts - A Unique Ratings System to Grade Catalysts - A Growing Focus on Upcoming Clinical Trial Catalysts - Direct Email Communication - Affiliate Program, earn $50 for every referral who joins If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe. You will be given immediate access to premium content on the site including: - Detailed Reports on Upcoming FDA / Clinical Trades - Analyst Reports with consistently updated summaries (Sample) - Run-Up Valuation Studies (Sample) - Weekly Newsletter (Sample) - Email / SMS (Text Message) Alerts of critical news (Sample) - Screenshots of BioRunUp's and Mike Havrilla's Trading Accounts - BioRunUp Forums - A community of informed traders - A More Detailed FDA Calendar - Increased Organization of Tracking Upcoming Catalysts - A Unique Ratings System to Grade Catalysts - A Growing Focus on Upcoming Clinical Trial Catalysts - Direct Email Communication - Affiliate Program, earn $50 for every referral who joins
|
Sorry this page is available to subscribers only.